[go: up one dir, main page]

AU2002220419A1 - Prolamin-based sustained-release compositions and delayed-onset compositions - Google Patents

Prolamin-based sustained-release compositions and delayed-onset compositions

Info

Publication number
AU2002220419A1
AU2002220419A1 AU2002220419A AU2041902A AU2002220419A1 AU 2002220419 A1 AU2002220419 A1 AU 2002220419A1 AU 2002220419 A AU2002220419 A AU 2002220419A AU 2041902 A AU2041902 A AU 2041902A AU 2002220419 A1 AU2002220419 A1 AU 2002220419A1
Authority
AU
Australia
Prior art keywords
compositions
prolamin
delayed
onset
based sustained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002220419A
Inventor
Johnatan Bacon
Alain Desjardins
Vincent Lenaerts
Miloud Rahmouni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Labopharm Inc
Original Assignee
Labopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labopharm Inc filed Critical Labopharm Inc
Publication of AU2002220419A1 publication Critical patent/AU2002220419A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2873—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002220419A 2000-12-01 2001-11-30 Prolamin-based sustained-release compositions and delayed-onset compositions Abandoned AU2002220419A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/728,840 US20020106408A1 (en) 2000-12-01 2000-12-01 Prolamin-based sustained-release compositions and delayed-onset compositions
US09/728,840 2000-12-01
PCT/CA2001/001716 WO2002043706A2 (en) 2000-12-01 2001-11-30 Prolamin-based sustained-release compositions and delayed-onset compositions

Publications (1)

Publication Number Publication Date
AU2002220419A1 true AU2002220419A1 (en) 2002-06-11

Family

ID=24928479

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002220419A Abandoned AU2002220419A1 (en) 2000-12-01 2001-11-30 Prolamin-based sustained-release compositions and delayed-onset compositions

Country Status (6)

Country Link
US (1) US20020106408A1 (en)
EP (1) EP1343482A2 (en)
AR (1) AR031772A1 (en)
AU (1) AU2002220419A1 (en)
CA (1) CA2433668A1 (en)
WO (1) WO2002043706A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003215671A1 (en) * 2002-03-22 2003-10-08 Cilag Ag Sustained release formulation of tramadol
AU2003272601B2 (en) * 2002-09-20 2009-05-07 Alpharma Pharmaceuticals, Llc Sustained-release opioid formulations and methods of use
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US20080187581A1 (en) * 2005-03-16 2008-08-07 Subhash Pandurang Gore Delivery System For Mulitple Drugs
RU2008113439A (en) 2005-09-09 2009-10-20 Лабофарм Инк. (CA) COMPOSITIONS WITH SLOW DELIVERY OF A MEDICINAL PRODUCT
CN101252932B (en) * 2005-09-09 2012-10-03 安吉利尼莱博法姆有限责任公司 Trazodone composition for once a day administration
US8148560B2 (en) * 2005-09-23 2012-04-03 Teva Women's Health, Inc. Vaginal tablets comprising misoprostol and methods of making and using the same
US20090004269A1 (en) * 2006-01-19 2009-01-01 The Curators Of The University Of Missouri Pharmaceutical Composition Comprising a Proton Pump Inhibitor and a Protein Component
EP2203166B1 (en) * 2007-10-16 2015-05-06 Paladin Labs Inc. Bilayer composition for the sustained release of acetaminophen and tramadol
NZ589742A (en) 2008-05-27 2012-06-29 Univ Melbourne Methods of treating mammals with eustachian tube dysfunctions with betahistine
CN102202654B (en) * 2008-09-04 2014-07-30 法纳姆公司 Chewable sustained release formulations
CN101843577A (en) * 2010-04-08 2010-09-29 安徽中医学院 Coating implant using zein as skeleton material and preparation method
EP2642872A1 (en) * 2010-11-26 2013-10-02 DSM IP Assets B.V. Protective hydrocolloid for active ingredients
CN102247368B (en) * 2011-05-19 2013-05-29 安徽永生堂药业有限责任公司 Compound acrivastine sustained release tablets, and preparation method thereof
WO2016046817A1 (en) * 2014-09-24 2016-03-31 Vital Beverages Global Inc. Compositions and methods for selective gi tract delivery
DE102015014581A1 (en) * 2015-11-12 2017-05-18 Nele Schmidt Prolamine-containing gels, process for their preparation and their use
CN117257740A (en) * 2022-06-13 2023-12-22 海南大学 Dexibuprofen enteric microsphere and preparation method thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB935672A (en) * 1960-07-19 1963-09-04 Sterling Drug Inc Sustained release tablet
US3477864A (en) * 1965-05-07 1969-11-11 Sumitomo Chemical Co Process for coating pharmaceutical preparations with a hydroxy propyl methyl cellulose-sealing agent moisture-preventing film
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions
US4007258A (en) * 1973-09-10 1977-02-08 Union Corporation Sustained release pesticidal composition
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
WO1991006227A1 (en) * 1989-11-06 1991-05-16 Opta Food Ingredients, Inc. Protein-based edible coatings
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
US5324351A (en) * 1992-08-13 1994-06-28 Euroceltique Aqueous dispersions of zein and preparation thereof
DE20023135U1 (en) * 2000-04-03 2003-04-03 Beisel, Günther, 40789 Monheim Agents with improved prolonged release

Also Published As

Publication number Publication date
EP1343482A2 (en) 2003-09-17
US20020106408A1 (en) 2002-08-08
AR031772A1 (en) 2003-10-01
CA2433668A1 (en) 2002-06-06
WO2002043706A3 (en) 2003-03-27
WO2002043706A2 (en) 2002-06-06
WO2002043706A9 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2002357119A1 (en) Mitocidal compositions and methods
AU2001250875A1 (en) Anti-microbial and immunostimulating composition
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2778801A (en) Antisense compositions and methods
AU2001265008A1 (en) Caspase inhibitors and uses thereof
AUPQ419099A0 (en) Novel compositions and methods
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2001253418A1 (en) Compounds and methods
AU2002220419A1 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
AU2002211717A1 (en) Stresscopins and their uses
AU2001272011A1 (en) Siderophores-producing bifidobacteria thereby and uses thereof
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU1152601A (en) Compositions and their use
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2001233932A1 (en) Method and composition
GB0027391D0 (en) Films and compositions
AU2001278951A1 (en) Compounds and methods
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2002239775A1 (en) Chemical-library composition and method
AU2002256556A1 (en) Sea-trosy and related methods
AU2001262928A1 (en) Pharmaceutical compositions and their use
AU2000251520A1 (en) Antiviral methods and compositions